Showing results (1181-1190 of 1,202) with videos related to
Sort By:
Pageof 121
Nature Medicine|April 25, 2018
Transcript-indexed ATAC-seq for precision immune profilingAnsuman T Satpathy, Naresha Saligrama, Jason D Buenrostro, et al.Nature Microbiology|January 10, 2025
Engineered Mycobacterium tuberculosis triple-kill-switch strain provides controlled tuberculosis infection in animal modelsXin Wang, Hongwei Su, Joshua B Wallach, et al.Circulation|March 18, 1997
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study GroupA L Hinderliter, P W Willis, R J Barst, et al.Cancer|October 15, 1981
Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study GroupC G Moertel, S Frytak, R G Hahn, et al.Cancer|July 1, 1978
Randomized phase II clinical trial of adriamycin, methotrexate, and actinomycin-D in advanced measurable pancreatic carcinoma: a Gastrointestinal Tumor Study Group ReportP S Schein, P T Lavin, C G Moertel, et al.Nature Genetics|September 26, 2017
Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elementsMaxwell R Mumbach, Ansuman T Satpathy, Evan A Boyle, et al.Cell|July 4, 2017
Development of a Novel Lead that Targets M. tuberculosis Polyketide Synthase 13Anup Aggarwal, Maloy K Parai, Nishant Shetty, et al.Annals of Internal Medicine|March 25, 2000
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trialD B Badesch, V F Tapson, M D McGoon, et al.Nature Chemical Biology|August 21, 2019
Mycobacterium tuberculosis releases an antacid that remodels phagosomesJeffrey Buter, Tan-Yun Cheng, Marwan Ghanem, et al.Nature Genetics|September 3, 2013
Genomic analysis identifies targets of convergent positive selection in drug-resistant Mycobacterium tuberculosisMaha R Farhat, B Jesse Shapiro, Karen J Kieser, et al.Pageof 121